46-60 of 243
Closing Care Gaps and Addressing Unmet Needs in SMA
NeuroFrontiersClosing Care Gaps and Addressing Unmet Needs in SMA
Jennifer Kwon, MD
Examining Care Collaborations for Patients with SMA
NeuroFrontiersExamining Care Collaborations for Patients with SMA
Andrew Wilner, MD, FACP, FAAN
Nassim Rad, MD
Vanessa Battista, RN
The Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
On the Frontlines of MigraineThe Genetics of Migraine: Advancing Diagnosis and Personalizing Treatment
Ryan Quigley
Lyn R. Griffiths
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
On the Frontlines of PsoriasisGenetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
Audrey Bui, DO
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiersQuantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
- advertisement
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiersCardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Balancing Benefits and Risks in Emerging Sickle Cell Therapies
Project Oncology®Balancing Benefits and Risks in Emerging Sickle Cell Therapies
Yogindra Persuad
Targeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Clinician's RoundtableTargeting Inflammation to Improve Gene Therapy Outcomes in Sickle Cell Disease
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiersGene Therapy Safety in DMD: How to Identify Common Immune Reactions
Kaitlin Batley, MD
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiersOptimizing DMD Care Through Multidisciplinary Collaboration
Kaitlin Batley, MD
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
George Laliotis, MD, MPH, MHA
- advertisement
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiersAnti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiersEvaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
